Startups
Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets.
Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments accessible to patients in international markets.
Medison has a track record of multi-territorial partnerships with leading pharmaceutical and biotech companies seeking to expand their global reach.
Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments accessible to patients in international markets.
Medison has a track record of multi-territorial partnerships with leading pharmaceutical and biotech companies seeking to expand their global reach.
Overview
Location
Israel, Center District, Petah Tikva
Employees
201-500
Founded date
1996
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 23, 2025 | Medison and Everest Medicines: Pioneering the Future of Global Biotech | In the ever-evolving landscape of biotechnology, two companies are making significant strides: Medison and Everest Medicines. Both are reshaping the way therapies reach patients, particularly in underserved markets. Their recent development... |
| Jun 18, 2025 | Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer | Strategic appointments reflect Medison's continued investment in global scale and operational excellence PETACH TIKVA, Israel, June 18, 2025 /PRNewswire/ -- Medison, the creator of a first-of-its-kind unified global commercialization platfo... |
| Sep 19, 2024 | 3 Genomics Stocks Transforming Healthcare Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals... | Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals (REGN), Al... |
| Apr 30, 2024 | Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia | The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance Medison, the creator and leader of the multi-regional partnership category, will utilize its unique... |
| Jan 8, 2024 | Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries | Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung cancer and advanced cervical c... |
| Nov 13, 2023 | Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC) | Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY... |
| Mar 9, 2023 | Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics | ZUG, Switzerland, March 9, 2023 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly inn... |
| Jan 10, 2023 | Sarah Otten Joins Medison Pharma as VP, GM Americas Region | Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. PETACH TIKVAH, Israel and ZUG, Switzerland, Jan. 9, 2023 /PRNewswire/ -- Mediso... |
| Nov 9, 2022 | Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America | With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therap... |
Show more
Reviews 0
FAQ about Medison Pharma
When was Medison Pharma founded?
Medison Pharma was founded in 1996.
What has the press written about Medison Pharma?
Parsers VC has collected 18 articles mentioning Medison Pharma, among them “Medison and Everest Medicines: Pioneering the Future of Global Biotech” (Jun 23, 2025) and “Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer” (Jun 18, 2025).
Is Medison Pharma still active?
Yes, Medison Pharma is active; its latest activity on Parsers VC dates from Oct 23, 2025.